CEPI allocated $375,000 just a few days after the WHO declared the disease a global health emergency.British health agencies have secured $375,000 to develop tools for a standardised approach to test the performance of vaccines against monkeypox.
The Coalition for Epidemic Preparedness Innovations, which allocated the fundings, made the announcement on Tuesday, a few days after the World Health Organisation (WHO) declared the virus a public health emergency of international concern.
The designation, which is the heath body’s highest level of alert, does not necessarily mean a disease is particularly transmissible or lethal. But it is key to unlocking funds and cooperation among countries to share vaccines and treatments.
The money will go, CEPI said, to the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the UK Health Security Agency (UKHSA) to develop standard tools to assess the strength and duration of immune responses generated by current vaccines, and for tests used to detect monkeypox antibody levels.
Apart from administration fees, these tools will be made freely available to the global scientific community, paving the way for a common standardised assessment between countries documenting vaccine performance against monkeypox, CEPI said.
Until this year, the viral disease had rarely spread outside Africa where it is endemic. But reports of a handful of cases in the United Kingdom in early May signalled that the outbreak had moved into Europe. So far, there have been more than 16,000 confirmed cases of monkeypox in more than 75 countries.
The fatality rate in preceding monkeypox outbreaks in Africa of the strain currently spreading has been about 1 percent, but so far this outbreak has …